We’re introducing Programmable Panels at AAI: Poster 721, Thursday, April 16, 11:30 AM Eastern. Sponsors open the studio at teiko-labs.com/design to move from trial planning to a documented panel design without email-only back-and-forth.
Panel design still splits across email, slides, and spreadsheets. The gating hierarchy and marker budget rarely sit in one place before validation. Sponsors and cytometry leads need that single view, including clone choices for the instrument, before the lab locks a design.
Programmable Panels starts from Teiko’s curated phenotype catalog. When sponsors select populations, the gating hierarchy updates in the browser. Functional readouts attach where they apply. Clone context reflects mass cytometry constraints. A running marker count compares to Teiko CyTOF backbone channel budgets (for example 33- and 41-channel products). Teiko scientists and the Artificial Immunologist answer questions on design, validation, and interpretation so decisions do not rely on guesswork.
After a sponsor submits a configuration, Teiko confirms scope. We check inventory for reusable antibodies and adjust cost when existing conjugates apply. We complete channel and reagent planning after that review. Sponsors do not commit to custom lab work before Teiko matches the panel to stock and backbone fit.
What sponsors get today: a visual specification they can share with their team. It matches how Teiko gates and reports.
What comes next: we’ll connect the tool to live conjugation and inventory, the same data the lab uses to build panels. That connection will show what can ship from existing conjugates versus what needs new metal work. Clearer quotes, fewer surprises, and a shorter path when the reagent is already on the shelf. Later releases will add lead-time estimates, and inventory-aware pricing.
.png)
